759 filings
Page 3 of 38
8-K
KPRX
Kiora Pharmaceuticals Inc
20 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
PRE 14A
KPRX
Kiora Pharmaceuticals Inc
Preliminary proxy
11 Jul 23
5:00pm
8-K
KPRX
Kiora Pharmaceuticals Inc
21 Jun 23
Submission of Matters to a Vote of Security Holders
4:25pm
8-K
KPRX
Kiora Pharmaceuticals Inc
15 Jun 23
Kiora Pharmaceuticals and Sentrx Animal Care Amend Existing Manufacturing Licensing Agreement for KIO-201
4:59pm
SC 13G
Lind Global Fund II LP
13 Jun 23
KIORA PHARMACEUTICALS / Lind Global Fund II ownership change
4:02pm
8-K
KPRX
Kiora Pharmaceuticals Inc
6 Jun 23
Kiora Pharmaceuticals Announces Pricing of $5.5 Million Underwritten Public Offering
4:52pm
424B1
KPRX
Kiora Pharmaceuticals Inc
2 Jun 23
Prospectus with pricing info
5:08pm
EFFECT
KPRX
Kiora Pharmaceuticals Inc
2 Jun 23
Notice of effectiveness
12:15am
S-1/A
KPRX
Kiora Pharmaceuticals Inc
IPO registration (amended)
31 May 23
6:01pm
CORRESP
KPRX
Kiora Pharmaceuticals Inc
31 May 23
Correspondence with SEC
12:00am
CORRESP
KPRX
Kiora Pharmaceuticals Inc
31 May 23
Correspondence with SEC
12:00am
CORRESP
KPRX
Kiora Pharmaceuticals Inc
24 May 23
Correspondence with SEC
12:00am
CORRESP
KPRX
Kiora Pharmaceuticals Inc
24 May 23
Correspondence with SEC
12:00am
CORRESP
KPRX
Kiora Pharmaceuticals Inc
23 May 23
Correspondence with SEC
12:00am
FWP
KPRX
Kiora Pharmaceuticals Inc
15 May 23
Free writing prospectus
5:18pm
S-1/A
KPRX
Kiora Pharmaceuticals Inc
IPO registration (amended)
12 May 23
5:03pm
8-K
KPRX
Kiora Pharmaceuticals Inc
9 May 23
Kiora Pharmaceuticals Reports First Quarter Results; Positive Clinical Data Driving Significant Progress Advancing Pipeline of Eye Disease Treatments
7:02am
10-Q
2023 Q1
KPRX
Kiora Pharmaceuticals Inc
Quarterly report
9 May 23
6:59am
UPLOAD
KPRX
Kiora Pharmaceuticals Inc
9 May 23
Letter from SEC
12:00am
S-1
KPRX
Kiora Pharmaceuticals Inc
IPO registration
5 May 23
5:01pm